此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

SCOPE-中国女性研究 (SCOPE)

2026年11月6日 更新者:University of California, San Francisco

基于智能手机的中国女性癌症和肥胖预防教育项目(SCOPE-中国女性)

This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The intervention will be tailored to the participants' behaviors, personal needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children in order to reduce the growing cancer burden in China.

研究概览

地位

完全的

详细说明

Cancer presents a major disease burden across the globe. The incidence and mortality of gynecologic cancers have increased significantly in China over the last two decades with breast and endometrial cancer as leading causes of death in women in China. Obesity, especially abdominal obesity, and unhealthy lifestyles are major risk factors for breast and endometrial cancer. A high risk group for obesity is mothers with dependent children as they have high levels of stress and family responsibilities that prevent regular engagement in a healthy lifestyle and early screening activities. Because reducing postmenopausal abdominal obesity is very difficult and because of the significant increased risk for gynecologic cancers in obese postmenopausal women, interventions that aim to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children are critical to reducing the growing cancer burden in China. A smartphone-based intervention provides a promising platform for obesity and cancer prevention. In this proposed study, the research team will modify the Healthy Mothers Healthy Children: Technology-Based Intervention to Prevent Obesity, which was developed by the principal investigator. The proposed intervention (titled "The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women: SCOPE-Chinese Women") is a smartphone-based, data-driven, and individually tailored intervention. It includes 12 weekly educational modules and six bi-weekly tailored messages delivered via WeChat, a popular communication app in China. The intervention will also be tailored to the participants' behaviors, personal needs, and preferences. The overall goal of this proposed study is to assess the feasibility and estimate the preliminary efficacy of the SCOPE-Chinese Women intervention using a randomized control study design (RCT). The following aims will be addressed.

Aim 1: To assess the feasibility of the smartphone-based lifestyle intervention (i.e., SCOPE-Chinese Women).

Aim 2: To estimate the preliminary efficacy of the SCOPE-Chinese Women intervention on the primary outcome (waist circumference) and secondary outcomes (body mass index, self-efficacy, food intake, physical activity, and metabolic risk) between the intervention and control groups at baseline, 3 months, and 6 months.

Aim 3: To understand participants' acceptance, barriers to adherence, and recommendations for intervention.

研究类型

介入性

注册 (实际的)

102

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Changsha, Hunan
      • Yuelucun、Changsha, Hunan、中国、410083
        • Central South University
    • California
      • San Francisco、California、美国、94143
        • University of California, San Francisco

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

Participants must:

  • Be female
  • Be at least 18 years old
  • Have a waist circumference great than 80 cm
  • Own a smartphone
  • Be able to read Chinese and speak Mandarin
  • Be premenopausal
  • Have a child between the age of 1 and 18 years old

Exclusion Criteria:

Women are excluded from the study if they:

  • Are pregnant
  • Gave birth less than 12 months prior to enrollment date
  • Have an acute or life-threatening disease (e.g., renal failure).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
无干预:Control

Participants in the control group will receive a Fitbit Alta-Heart Rate (HR) and 12 weekly non-tailored educational modules via WeChat on general health topics that are important to 20-45 year-old women in China. Topics include intimate partner violence, anxiety, depression, sexually transmitted infections, HIV, unintended pregnancy, hepatitis B, and general cancer prevention.

实验性的:SCOPE-Chinese Women Intervention

SCOPE-Chinese Women intervention content and methods: SCOPE-Chinese Women is a smartphone- based intervention.

Component 1. All study participants will receive a Fitbit Alta-HR tracking device to wear daily. Each participant will receive in-person, training on how to access the app and their tracking data. If a participant has not used the fitness device and app for more than one week, a WeChat reminder message will be sent to the participant.

Component 2. Participants will receive 12 weekly culturally appropriate and evidence-based SCOPE-Chinese Women educational modules along with tailored tips and messages via WeChat. Each module will include three educational sessions that last less than 45 minutes total.

Component 3. Six bi-weekly messages will be sent to participants via WeChat to encourage positive behavioral changes. Each participant's message content will be based on the participant's tracker information, personal goals, and preferences.

SCOPE-Chinese Women is a smart-phone based intervention that includes a Fitbit tracking device to monitor daily activity, 12-weeks of educational modules delivered by WeChat, and Bi-weekly messages that encourage positive behavioral change. The data will be examined by the research team to assess efficacy of the intervention.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Mean Change in Waist Circumference Over Time
大体时间:Baseline, 3 months, and 6 months

The National Institutes of Health (NIH) waist circumference measurement protocol will be used to measure change in waist circumference for each participant over time.

Baseline, 3 months, and 6 months

次要结果测量

结果测量
措施说明
大体时间
Mean Change in Body Mass Index (BMI) Over Time
大体时间:Baseline, 3 months, and 6 months

Weight and height will be used to compute the BMI with the formula=weight (kilograms(kg)) / height in (meters squared (m2). Changes in BMI will be collected for each participant over time.

Baseline, 3 months, and 6 months
Mean Change in Scores on the Self-Rated Abilities for Health Practices Scale Over Time
大体时间:Baseline, 3 months, and 6 months

The Self Rated Abilities for Health Practices Scale (SRAHP) is a 28-item survey, with each item scored on a 5-point scale, with item scores ranging from 0=Not at all to 4=Completely. The survey is designed to measure self-perceived ability to implement health-promoting behaviors across four subscales: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being, and overall. The total score ranges from 0 - 112, with higher scores indicating greater abilities for health practices. Changes in scores will be collected for each participant over time.

Baseline, 3 months, and 6 months
Mean Changes in China Food Frequency Questionnaire (FFQ) over time.
大体时间:Baseline, 3 months, and 6 months

Food intake using the China food frequency questionnaire (FFQ), which includes a list of 118 food items will be used to measure aggregate changes in food intake over time.

Baseline, 3 months, and 6 months
Mean Changes in Overall Physical Activity
大体时间:Baseline, 3 months, and 6 months

Change in overall Physical activity over time will be measured using the Fitbit Alta-HR device for 10 hours while participants are awake.

Baseline, 3 months, and 6 months
Mean Change in Blood Pressure Over Time
大体时间:Baseline, 3 months, and 6 months

Changes in blood pressure will be measured using the YuWell YE690A monitor for each participant over time.

Baseline, 3 months, and 6 months
Mean Change in Hemoglobin A1C (HbA1C) Over Time
大体时间:Baseline and 6 months

A blood sample will be collected to measure change in HbA1C over time for each participant, using an established cut off value at 6.4%.

Baseline and 6 months
Mean Change in Serum Lipid Levels Over Time
大体时间:Baseline and 6 months

A blood sample will be collected to measure change in total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides (all measured in milligrams per deciliter (mg/dL)) over time for each participant

Baseline and 6 months
Mean Change in Cortisol over time
大体时间:Baseline and 6 months

A blood sample will be collected to measure change in total cortisol levels over time for each participant.

Baseline and 6 months
Relative telomere length (RTL)
大体时间:baseline and 6 months follow-up.

A blood sample will be collected to measure relative telomere length (RTL), assessed using the real-time quantitative polymerase chain reaction (qPCR) technique, adhering to the protocol specified by Cawthon.

baseline and 6 months follow-up.

其他结果措施

结果测量
措施说明
大体时间
Percentage of Eligible participants Who Agree To Be Screened
大体时间:At Baseline

The number of overall eligible participants and the number of eligible participants who agree to be screened will be used to compute the percentage used for enrollment.

At Baseline
Number of Uses of The Tracking App Over Time
大体时间:Baseline to 6 months

The number of uses of the tracking app and frequency of accessing the 12 modules, to measure change in usability over time

Baseline to 6 months
Percentage of Participants who completed assessments
大体时间:Up to 6 months

The percentage of completed assessments by participants at each visit will be used to measure adherence over time

Up to 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jyu-Lin Chen, RN, PhD、University of California, San Francisco
  • 首席研究员:Jia Guo, RN, PhD、Central South Univeristy

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年7月20日

初级完成 (实际的)

2022年12月30日

研究完成 (实际的)

2022年12月30日

研究注册日期

首次提交

2020年3月23日

首先提交符合 QC 标准的

2020年3月26日

首次发布 (实际的)

2020年3月30日

研究记录更新

最后更新发布 (实际的)

2026年11月10日

上次提交的符合 QC 标准的更新

2026年11月6日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅